Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas

Carlos Murga-Zamalloa, Avery Polk, Walter Hanel, Pinki Chowdhury, Noah Brown, Alexandra C. Hristov, Nathanael G. Bailey, Tianjiao Wang, Tycel Phillips, Sumana Devata, Pradeep Poonnen, Juan Gomez-Gelvez, Kedar V. Inamdar, Ryan A. Wilcox

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)114474-114480
Number of pages7
JournalOncotarget
Volume8
Issue number70
DOIs
StatePublished - Jan 1 2017

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • C-myc
  • GATA-3
  • PLK-1
  • T-cell lymphoma
  • Volasertib

Disciplines

  • Medical Specialties
  • Medicine and Health Sciences
  • Pediatrics

Cite this